Loading...

Progyny, Inc.

PGNYNASDAQ
Healthcare
Medical - Healthcare Information Services
$23.11
$0.11(0.48%)

Progyny, Inc. (PGNY) Stock Overview

Explore Progyny, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 78.5/100

Key Financials

Market Cap2B
P/E Ratio37.96
EPS (TTM)$0.57
ROE0.12%
Fundamental Analysis

AI Price Forecasts

1 Week$21.68
1 Month$22.05
3 Months$14.13
1 Year Target$19.22

PGNY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Progyny, Inc. (PGNY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 55.94, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $19.22.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 37.96 and a market capitalization of 2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;